Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vectors01:30

Vectors

480
Vectors are mathematical entities characterized by both magnitude and direction. Unlike scalars, which are defined solely by magnitude, vectors represent quantities like displacement, velocity, and force, where direction is essential. Vectors are graphically represented as directed line segments, extending from an initial point to a terminal point, denoted with bold letters or arrows placed above the symbol. Two vectors are deemed equal if they share identical magnitudes and directions,...
480
Acceleration Vectors01:30

Acceleration Vectors

22.6K
In everyday conversation, accelerating means speeding up. Acceleration is a vector in the same direction as the change in velocity, Δv, therefore the greater the acceleration, the greater the change in velocity over a given time. Since velocity is a vector, it can change in magnitude, direction, or both. Thus acceleration is a change in speed or direction, or both. For example, if a runner traveling at 10 km/h due east slows to a stop, reverses direction, and continues their run at 10 km/h...
22.6K
Vector Operations01:20

Vector Operations

2.3K
Vectors are physical quantities that have both magnitude and direction. The vector operations include addition, subtraction, and scalar multiplication.
A vector multiplied by a scalar value is called scalar multiplication. The result obtained is a new vector with a different magnitude. If the scalar is positive, the direction of the vector remains the same, but if it is negative, the direction of the vector is reversed. For example, the product of the mass and velocity yields the momentum.
2.3K
Force Vector along a Line01:26

Force Vector along a Line

1.1K
Quite often in three-dimensional statics problems, the direction of a force is specified by two points through which its line of action passes. Consider a three-dimensional static pole with a cable anchored to the ground.
1.1K
Scalar and Vectors01:22

Scalar and Vectors

2.2K
In mechanics, commonly used terms like force, speed, velocity, and work can be classified as either scalar or vector quantities. A scalar is a physical quantity that can be described by its magnitude alone and does not require any directional components. Examples of scalar quantities are mass, area, and length.
Scalar quantities with the same physical units can be added or subtracted according to the usual algebra rules for numbers. For example, a class ending 10 min earlier than 50 min lasts...
2.2K
Introduction to Vectors01:21

Introduction to Vectors

35.6K
To define some physical quantities, there is a need to specify both magnitude as well as direction. For example, when the U.S. Coast Guard dispatches a ship or a helicopter for a rescue mission, the rescue team needs to know not only the distance to the distress signal, but also the direction from which the signal is coming, so that they can get to it as quickly as possible. Physical quantities specified completely with a number of units (magnitude) and a direction are called vector quantities.
35.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RNA activation as a precision dosing modality: MTL-CEBPA for controlled enzyme elevation in MPS I-H.

Frontiers in medicine·2026
Same author

Comprehensive analysis of hearing function in Morquio A syndrome: Implications for diagnosis and management.

Molecular genetics and metabolism·2026
Same author

Natural History of Morquio A Syndrome.

Journal of inherited metabolic disease·2026
Same author

Synthesis of and characterization of differentially sulfated disaccharide repeating units of keratan sulfate.

Glycoscience & therapy·2026
Same author

AAV Gene Therapy for MPS IVA with Induction of Immune Tolerance via Oral Administration of Epitope Peptides of N-Acetylgalactosamine-6-sulfate Sulfatase.

International journal of molecular sciences·2026
Same author

Collagen Type II-Targeting Lentiviral Gene Therapy for Mucopolysaccharidosis IVA.

Current issues in molecular biology·2026
Same journal

Bob Sun: ECI Biocommentary.

Pediatric research·2026
Same journal

The involvement of Anaeroplasma, caproic acid, and interleukins through the brain-gut axis may contribute to IgAV with neurological involvement.

Pediatric research·2026
Same journal

Emerging role of microplastics and nanoplastics in children's health.

Pediatric research·2026
Same journal

Serum cytokine profiling reveals distinct inflammatory signatures in Kawasaki disease and MIS-C and suggests associations with coronary artery lesions.

Pediatric research·2026
Same journal

Protective effects of dexpanthenol on experimental colitis in young rats: modulation of p53/BAX/BCL2 and RIPK1/RIPK3/MLKL signaling with anti-inflammatory activity.

Pediatric research·2026
Same journal

Born under pressure: cardiac adaptation in congenital diaphragmatic hernia.

Pediatric research·2026
See all related articles

Related Experiment Video

Updated: Feb 3, 2026

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Published on: October 18, 2022

5.2K

Tailoring the AAV2 capsid vector for bone-targeting.

Carlos J Alméciga-Díaz1, Adriana M Montaño2, Luis A Barrera3

  • 1Institute for the Study of Inborn Errors of Metabolism, Pontificia Universidad Javeriana, Bogotá, DC, Colombia. cjalmeciga@javeriana.edu.co.

Pediatric Research
|October 17, 2018
PubMed
Summary
This summary is machine-generated.

Researchers engineered an adeno-associated virus 2 (AAV2) vector with a bone-targeting peptide for enhanced gene delivery to bone. This modified vector shows improved hydroxyapatite (HA) affinity and enzyme activity, offering a new strategy for treating bone diseases.

More Related Videos

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
08:14

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

8.9K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.8K

Related Experiment Videos

Last Updated: Feb 3, 2026

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Published on: October 18, 2022

5.2K
Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
08:14

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

8.9K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.8K

Area of Science:

  • Gene Therapy
  • Biotechnology
  • Molecular Biology

Background:

  • Targeting specific tissues is a significant hurdle in gene therapy.
  • Adeno-associated virus 2 (AAV2) vectors have shown limited success in targeting bone.
  • Mucopolysaccharidosis IVA is a genetic disorder affecting bone.

Purpose of the Study:

  • To evaluate the affinity of an AAV2 vector to bone matrix (hydroxyapatite, HA) for treating Mucopolysaccharidosis IVA.
  • To enhance the bone-targeting capability of AAV2 vectors.
  • To assess the in vitro and in vivo performance of a modified AAV2 vector.

Main Methods:

  • An aspartic acid octapeptide (D8) was engineered into the AAV2 capsid (VP2 protein) to increase HA affinity.
  • The modified vector's physical titers and transduction efficiencies were compared to the unmodified vector.
  • In vitro and in vivo studies were conducted to assess HA affinity, vector genome copies in bone, and enzyme activity.

Main Results:

  • The modified bone-targeting vector demonstrated significantly higher HA affinity and vector genome copies in bone compared to the unmodified vector.
  • The modified vector showed sustained release from HA.
  • Enzyme activity in bone was 4.7-fold higher in the modified vector group 3 months post-infusion.

Conclusions:

  • Incorporating a bone-targeting peptide into the AAV2 vector capsid enhances gene delivery and expression in bone.
  • This strategy improves therapeutic enzyme expression in bone without compromising overall expression.
  • This approach presents a novel therapeutic strategy for systemic bone diseases.